“Moderna and Merck unveiled an mRNA based cancer vaccine that cuts the spread of melanoma. Merck's shares didn't do as well. They they jumped, but you know, they're obviously a bigger company, a lot more diversified.”
No settled horizons yet — outcomes appear at 30/90/365 days.